ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 97 filers reported holding ALBIREO PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $29,443,284 | +35.8% | 1,362,484 | +21.7% | 1.63% | +29.9% |
| Q3 2022 | $21,679,000 | -19.2% | 1,119,774 | -17.1% | 1.25% | -15.4% |
| Q2 2022 | $26,836,000 | -11.1% | 1,351,234 | +33.6% | 1.48% | +14.2% |
| Q1 2022 | $30,180,000 | +52.6% | 1,011,744 | +19.1% | 1.30% | +76.3% |
| Q4 2021 | $19,779,000 | -22.7% | 849,239 | +3.6% | 0.74% | -24.0% |
| Q3 2021 | $25,576,000 | +4.3% | 819,738 | +17.6% | 0.97% | +1.1% |
| Q2 2021 | $24,529,000 | +1.4% | 697,236 | +1.6% | 0.96% | -6.1% |
| Q1 2021 | $24,193,000 | +4.3% | 686,338 | +11.0% | 1.02% | -1.4% |
| Q4 2020 | $23,191,000 | +36.2% | 618,263 | +21.1% | 1.04% | +18.3% |
| Q3 2020 | $17,033,000 | +28.0% | 510,443 | +1.6% | 0.88% | +13.6% |
| Q2 2020 | $13,304,000 | +64.9% | 502,212 | +1.9% | 0.77% | +18.4% |
| Q1 2020 | $8,068,000 | +81.1% | 492,878 | +181.2% | 0.65% | +139.3% |
| Q4 2019 | $4,456,000 | +0.1% | 175,289 | -21.2% | 0.27% | -8.7% |
| Q3 2019 | $4,451,000 | -31.7% | 222,549 | +10.0% | 0.30% | -28.5% |
| Q2 2019 | $6,520,000 | +6.9% | 202,241 | +6.8% | 0.42% | +0.5% |
| Q1 2019 | $6,101,000 | +37.5% | 189,408 | +4.7% | 0.42% | +14.6% |
| Q4 2018 | $4,438,000 | -16.0% | 180,911 | +12.9% | 0.36% | -0.8% |
| Q3 2018 | $5,282,000 | +10.4% | 160,248 | +18.9% | 0.36% | -5.4% |
| Q2 2018 | $4,784,000 | +61.7% | 134,748 | +48.4% | 0.39% | -2.3% |
| Q1 2018 | $2,958,000 | – | 90,831 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |